Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2007 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,901 | 4,131 | N/A | N/A | N/A |
| Marketable Securities | 23 | 23 | N/A | N/A | N/A |
| Receivables | 236 | 699 | N/A | N/A | N/A |
| Inventories | 30 | 80 | N/A | N/A | N/A |
| TOTAL | $8,353 | $5,147 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 48 | 61 | N/A | N/A | N/A |
| TOTAL | $48 | $61 | $N/A | $N/A | $N/A |
| Total Assets | $8,401 | $5,208 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 41 | 40 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 995 | 988 | 0 | 0 | 0 |
| TOTAL | $1,036 | $1,028 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 715 | 812 | N/A | N/A | N/A |
| TOTAL | $715 | $812 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,751 | $1,841 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 15,782 | 8,444 | N/A | N/A | N/A |
| Retained earnings | -12,499 | -8,542 | N/A | N/A | N/A |
| Other shareholders' equity | 2,004 | 2,468 | 0 | 0 | 0 |
| TOTAL | $6,650 | $3,368 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $8,401 | $5,208 | $0 | $0 | $0 |